Search Results - "chimeric antigen receptor-t cell"

Chimeric Antigen Receptor-Engineered Cell Membrane-Coated Nanoparticles Promote Dual-Targeted mRNA-Based Cancer Gene Therapy

Lei, Sibei^{aff1, aff3}, Li, Jingmei^aff1, Zhu, Manfang^aff2, Zhou, Weilin^aff1, Fu, Xizi^aff1, Wu, Shan^aff1, Chen, Xiayu^aff1, Zhang, Jin^aff1, Duan, Xingmei^aff2, Wang, Wei^aff1, Men, Ke^aff1

Lipopolysaccharide Induces Resistance to CAR‑T Cell Therapy of Colorectal Cancer Cells through TGF-β-Mediated Stemness Enhancement

Tao, Min^{aff1, aff2, aff3}, Xue, Mengmeng^{aff1, aff2, aff3}, Zhou, Daoyu^aff3, Zhang, Luyao^aff3, Hou, Xiaojuan^aff4, Zhu, Xinyu^aff3, Feng, Shiyao^aff5, Yan, Haixin^aff6, Qian, Xiaofeng^aff7, Wei, Lixin^aff4, Zong, Chen^aff4, Yang, Xue^aff4, Zhang, Li^{aff2, aff1, aff3}

Nephrotoxicity of CAR-T therapy in patients with relapsed and refractory multiple myeloma

Chen, Zihan^Aff1, Chen, Yegan^Aff1, Liu, Jiaying, Sun, Yingjun, Zhang, Xiaoxue, Shao, Lingyan, Wang, Dandan, Wang, Xue, Chen, Wei, Sang, Wei, Qi, Kunming, Li, Zhenyu, Sun, Cai, Shi, Ming, Qiao, Jianlin, Wu, Qingyun, Zeng, Lingyu, Zheng, Junnian, Xu, Kailin, Li, Li^{Aff4, IDs11255025045034_cor1}, Cheng, Hai^{Aff1, IDs11255025045034_cor2}, Cao, Jiang^{Aff1, IDs11255025045034_cor3}

Simple and early prediction of severe CAR-T-related adverse events after Axi-cel infusion by initial high fever

Wakabayashi, Hiroya, Terakura, Seitaro^{Aff1, IDs12185025039577_cor1}, Ishigiwa, Kohei, Ohara, Fumiya, Hirano, Shiho, Yokota, Hirofumi, Kuwano, Shihomi, Furukawa, Katsuya, Shimada, Kazuyuki, Sato, Takahiko, Hanajiri, Ryo^{Aff1, IDs12185025039577_cor2}, Kiyoi, Hitoshi

FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective

Thirumalaisamy, R.^{Aff1, IDs12033024010900_cor1}, Vasuki, S., Sindhu, S. M.^{Aff1, Aff2}, Mothilal, T. M., Srimathi, V., Poornima, B., Bhuvaneswari, M., Hariharan, Mohan

Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma

Ma, Jin-Feng^{Aff1, Aff2}, Yan, Chun-Long^Aff3, Jia, Xu^Aff4, Zhu, Hong-Jia^Aff4, Yan, Jia-Wei^{Aff2, Aff5}, Liu, Mei-Jing^{Aff2, Aff5}, Zhang, Dai-Yi, Liu, Shen-Hao^{Aff2, Aff5}, Xu, Nan, Zhang, Hai-Guo, Ye, Ling, Yu, Lei, Wu, De-Pei^{Aff2, Aff5, IDs0027702406132w_cor1}, Gong, Wen-Jie^{Aff2, Aff5, IDs0027702406132w_cor2}, Dai, Hai-Ping^{Aff2, Aff5, IDs0027702406132w_cor3}, Xue, Sheng-Li^{Aff2, Aff5, IDs0027702406132w_cor4}

Cellular Therapies: From a Theoretical Concept to an Immuno-augmented Reality

Cherukuri, Pratima^Aff3, Khan, Aalia N.^Aff4, Gera, Karan^Aff5, Karulkar, Atharva^Aff5, Asija, Sweety^Aff4, Banik, Ankit^Aff4, Purwar, Rahul^{Aff4, Aff5}

Chirmule, Narendra, editor^Aff1, Ghalsasi, Vihang Vivek, editor^Aff2

CAR T-cell therapy in renal cell carcinoma: opportunities, challenges, and new strategies to overcome

Mohammadi, Mahan, Najafi, Houshang^{Aff1, Aff2, IDs1203202502735z_cor1}, Mohammadi, Pantea

Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence

Ho, Mu-Hsing, Cheung, Denise Shuk Ting, Wang, Tongyao, Wang, Lizhen, Wong, Justin Wei Ho, Lin, Chia-Chin^{Aff1, Aff2, IDs00520025093562_cor1}

Venous Thromboembolism Risk in Hematological Malignancies Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Meta-Analysis of Phase 2 and Phase 3 Clinical Trials.

Chitkara, Akshit, Sreenivasan, Sushanth, Yin, Yue, Rai, Maitreyee, Sadashiv, Santhosh

application/pdf

Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma

Sahand Saeidpour Masouleh, Kamyar Nasiri, Ava Ostovar Ravari, Mona Saligheh Rad, Kiarash kiani, Ali Sharifi Sultani, Seyedeh Tabasom Nejati, Mohsen Nabi Afjadi

electronic resource

View item

The management of multiple myeloma patients accompanied with disseminated intravascular coagulation before receiving LCAR-B38M therapy

Ruijun Dong, Rui Liu, Rui Yang, Yun Yang, Yan Xu, Bo Lei, Wanhong Zhao, Wanggang Zhang, Gongzhizi Gao, Aili He, Ju Bai

electronic resource

View item

Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma

Tianshu Yu, Xianhuo Wang, Ou Bai, Huilai Zhang, Wenbin Qian

electronic resource

View item; View item

Efficacy of MET-targeting CAR T cells against glioblastoma patient-derived xenograft models

Anna Qin, Anna Musket, Benjamin Hilton, Johanna Preiszner, Giedre Krenciute, Michael E. Berens, Mingyao Ying, Phillip R. Musich, Qian Xie

electronic resource

View item

Efficacy and safety comparison of CAR-T and blinatumomab immunotherapy as bridge-to-transplant strategies in relapsed/refractory B cell acute lymphoblastic leukemia

Wenyue Cao, Ningwen Li, Gaoxiang Wang, Hao Xu, Yang Yang, Jue Wang, Jinhuan Xu, Yun Li, Yicheng Zhang, Yang Cao, Na Wang

electronic resource

View item

Mapping the landscape: a bibliometric study of global chimeric antigen receptor T cell immunotherapy research

Zhang, Wenhao^{Aff1, Aff2, Aff3}, Wei, Wenzhuo, Ma, Lijun, Du, He, Jin, Anran, Luo, Jinyi, Li, Xiaoming^{Aff1, Aff2, IDs00210024032586_cor7}

Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion

Li, Yangzi^{Aff1, Aff2}, Cui, Qingya^{Aff1, Aff2}, Liu, Sining^{Aff1, Aff2}, Liu, Lingling^{Aff1, Aff2}, Li, Megyn^{Aff1, Aff2}, Gao, Jun^{Aff1, Aff2}, Li, Zheng^{Aff1, Aff2}, Cui, Wei^{Aff1, Aff2}, Zhu, Xiaming^{Aff1, Aff2}, Kang, Liqing^{Aff3, Aff4}, Yu, Lei^{Aff3, Aff4}, Wu, Depei^{Aff1, Aff2, IDs13402024009457_cor12}, Tang, Xiaowen^{Aff1, Aff2, IDs13402024009457_cor13}

Research status and prospects of treatment for malignant pleural mesothelioma

ZHAO Kaile, WANG Lei, GENG Jianxiong, CUI Chengwei, YU Yan

electronic resource

View item; View item

IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment

Zhaorong Wu, Hongye Wang, Zhigang Zheng, Yan Lin, Linke Bian, Haigang Geng, Xiaorong Huang, Jiufei Zhu, Hongshu Jing, Yi Zhang, Chen ji, Bo Zhai

electronic resource

View item

Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy

Goel U, Zanwar S, Cowan AJ, Banerjee R, Khouri J, Dima D

electronic resource

View item; View item